Wanbangde Pharmaceutical Holding Group Co Ltd - Class A

SZSE:002082 (China)   Class A
Â¥ 4.50 (-1.96%) Jun 13
54.88
P/B:
1.03
Market Cap:
Â¥ 2.78B ($ 382.73M)
Enterprise V:
Â¥ 3.66B ($ 504.11M)
Volume:
3.65M
Avg Vol (2M):
5.12M
Volume:
3.65M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Wanbangde Pharmaceutical Holding Group Co Ltd ( SZSE:002082 ) from 2006 to Jun 13 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Wanbangde Pharmaceutical Holding Group stock (SZSE:002082) PE ratio as of Jun 13 2024 is 54.88. More Details

Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) PE Ratio (TTM) Chart

To

Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) PE Ratio (TTM) Historical Data

Total 1203
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Wanbangde Pharmaceutical Holding Group PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-13 54.9 2024-04-03 61.6
2024-06-12 56.0 2024-04-02 61.8
2024-06-11 54.8 2024-04-01 61.6
2024-06-07 54.4 2024-03-29 60.5
2024-06-06 52.0 2024-03-28 60.1
2024-06-05 55.2 2024-03-27 61.8
2024-06-04 56.6 2024-03-26 62.3
2024-06-03 57.3 2024-03-25 62.4
2024-05-31 59.4 2024-03-22 64.2
2024-05-30 59.1 2024-03-21 65.7
2024-05-29 59.6 2024-03-20 65.7
2024-05-28 59.6 2024-03-19 64.8
2024-05-27 60.2 2024-03-18 65.1
2024-05-24 60.1 2024-03-15 63.7
2024-05-23 59.9 2024-03-14 63.0
2024-05-22 61.3 2024-03-13 62.8
2024-05-21 61.5 2024-03-12 63.4
2024-05-20 62.0 2024-03-11 61.0
2024-05-17 62.3 2024-03-08 59.8
2024-05-16 62.7 2024-03-07 59.9
2024-05-15 62.3 2024-03-06 62.7
2024-05-14 63.0 2024-03-05 59.6
2024-05-13 62.2 2024-03-04 61.6
2024-05-10 63.2 2024-03-01 61.8
2024-05-09 64.8 2024-02-29 61.1
2024-05-08 64.0 2024-02-28 59.0
2024-05-07 62.7 2024-02-27 63.8
2024-05-06 62.7 2024-02-26 63.0
2024-04-30 60.4 2024-02-23 61.1
2024-04-29 59.4 2024-02-22 59.2
2024-04-26 57.3 2024-02-21 58.1
2024-04-25 56.2 2024-02-20 56.5
2024-04-24 55.1 2024-02-19 55.6
2024-04-23 53.2 2024-02-08 53.7
2024-04-22 51.6 2024-02-07 49.8
2024-04-19 51.8 2024-02-06 51.9
2024-04-18 52.3 2024-02-05 53.4
2024-04-17 54.0 2024-02-02 59.4
2024-04-16 49.9 2024-02-01 63.7
2024-04-15 54.1 2024-01-31 65.3
2024-04-12 57.4 2024-01-30 69.6
2024-04-11 58.9 2024-01-29 71.9
2024-04-10 59.5 2024-01-26 74.0
2024-04-09 61.1 2024-01-25 73.4
2024-04-08 58.7 2024-01-24 70.1

Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Wanbangde Pharmaceutical Holding Group Co Ltd
NAICS : 212299 SIC : 3334
ISIN : CNE000001P94

Share Class Description:

SZSE:002082: Class A
Description
Wanbangde Pharmaceutical Holding Group Co Ltd is mainly engaged in the pharmaceutical manufacturing and medical equipment-based health industry.